methyllycaconitine has been researched along with Co-infection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Chi, F; Huang, SH; Jong, A; Liu, LQ; Peng, L; Wang, SF; Wu, CH; Yu, JY; Zhang, B | 1 |
1 other study(ies) available for methyllycaconitine and Co-infection
| Article | Year |
|---|---|
Alpha7 nicotinic acetylcholine receptor is required for blood-brain barrier injury-related CNS disorders caused by Cryptococcus neoformans and HIV-1 associated comorbidity factors.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Blood-Brain Barrier; Central Nervous System Stimulants; Coinfection; Cryptococcus neoformans; HIV Envelope Protein gp41; HIV Infections; HIV-1; Inflammation; Meningitis, Cryptococcal; Methamphetamine; Mice; Mice, Knockout; NF-kappa B; Nicotinic Antagonists | 2015 |